ProfileGDS2971 / 7.2.4.20
TitleHemiasterlin analog HTI-286 effect on docetaxel-resistant prostate cancer cell line
OrganismHomo sapiens


HTI-286 docetaxel GSM206100 GSM206166 GSM206167 GSM206168 GSM206169 GSM206170 GSM206357 GSM206358 GSM206359 GSM206360 GSM206361 GSM206362 85% 51% 27% 46% 79% 95% 86% 31% 84% 52% 19% 9% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM206100HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 1)0.85059285
GSM206166HTI-286 in docetaxel-refractory prostate cancer (Dye Flip 1)0.072651251
GSM206167HTI-286 in docetaxel-refractory prostate cancer Biological Replicate 2-0.30300927
GSM206168HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 3)-0.048406846
GSM206169HTI-286 in docetaxel-refractory prostate cancer (Dye flip2)0.4377379
GSM206170HTI-286 in docetaxel-refractory prostate cancer (dyeflip3)1.3087595
GSM206357HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip1)0.86658186
GSM206358HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate1)-0.31561731
GSM206359HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip2)0.76375684
GSM206360HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate2)0.088132552
GSM206361HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip3)-0.58580819
GSM206362HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate3)-1.250699